Literature DB >> 9119478

Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

P A Kozlowski1, S Cu-Uvin, M R Neutra, T P Flanigan.   

Abstract

To determine which mucosal immunization routes may be optimal for induction of antibodies in the rectum and female genital tract, groups of women were immunized a total of three times either orally, rectally, or vaginally with a cholera vaccine containing killed Vibrio cholerae cells and the recombinant cholera toxin B (CTB) subunit. Systemic and mucosal antibody responses were assessed at 2-week intervals by quantitation of CTB-specific antibodies in serum and in secretions collected directly from mucosal surfaces of the oral cavity, rectum, cervix, and vagina with absorbent wicks. The three immunization routes increased levels of specific immunoglobulin G (IgG) in serum and specific IgA in saliva to similar extents. Rectal immunization was superior to other routes for inducing high levels of specific IgA and IgG in rectal secretions but was least effective for generating antibodies in female genital tract secretions. Only vaginal immunization significantly increased both specific IgA and specific IgG in both the cervix and the vagina. In addition, local production of CTB-specific IgG in the genital tract could be demonstrated only in vaginally immunized women. Vaginal immunization did not generate antibodies in the rectum, however. Thus, generation of optimal immune responses to sexually transmitted organisms in both the rectal and the genital mucosae of women may require local immunization at both of these sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119478      PMCID: PMC175144          DOI: 10.1128/iai.65.4.1387-1394.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein.

Authors:  T Lehner; L A Bergmeier; C Panagiotidi; L Tao; R Brookes; L S Klavinskis; P Walker; J Walker; R G Ward; L Hussain
Journal:  Science       Date:  1992-11-20       Impact factor: 47.728

2.  Local antibody response to poliovaccine in the human female genital tract.

Authors:  P L Ogra; S S Ogra
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

3.  Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

4.  Quantitative analysis of immunoglobulins and albumin in secretion of female reproductive tract.

Authors:  A Tjokronegoro; S Sirisinha
Journal:  Fertil Steril       Date:  1975-05       Impact factor: 7.329

5.  A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

Authors:  S Hopkins; J P Kraehenbuhl; F Schödel; A Potts; D Peterson; P de Grandi; D Nardelli-Haefliger
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen.

Authors:  S L Jain; K S Barone; M P Flanagan; J G Michael
Journal:  Vaccine       Date:  1996-01       Impact factor: 3.641

Review 7.  Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines.

Authors:  J Mestecky; S Jackson
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

8.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  Systemic and secretory humoral immunity in the normal human vaginal tract.

Authors:  H Hocini; A Barra; L Bélec; S Iscaki; J L Preud'homme; J Pillot; J P Bouvet
Journal:  Scand J Immunol       Date:  1995-08       Impact factor: 3.487

10.  Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract.

Authors:  J Srinivasan; S Tinge; R Wright; J C Herr; R Curtiss
Journal:  Biol Reprod       Date:  1995-08       Impact factor: 4.285

View more
  104 in total

1.  Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.

Authors:  E L Johansson; L Wassén; J Holmgren; M Jertborn; A Rudin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

Authors:  H Y Wu; S Abdu; D Stinson; M W Russell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques.

Authors:  M Vajdy; R S Veazey; H K Knight; A A Lackner; M R Neutra
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.

Authors:  Jin Qiu; Lin Yan; Jianbo Chen; Crystal Y Chen; Ling Shen; Norman L Letvin; Barton F Haynes; Nancy Freitag; Lijun Rong; James T Frencher; Dan Huang; Xunming Wang; Zheng W Chen
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

Review 5.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 6.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

7.  Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Authors:  Amando Zuniga; Mathias Liniger; Teldja Neige Azzouz Morin; René R Marty; Marian Wiegand; Orhan Ilter; Sara Weibel; Martin A Billeter; Marlyse C Knuchel; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

8.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs.

Authors:  Jaehyung Park; Renuka Ramanathan; Linhchi Pham; Kim A Woodrow
Journal:  Nanomedicine       Date:  2017-04-20       Impact factor: 5.307

10.  Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.

Authors:  Lotta Wassen; Marianne Jertborn
Journal:  Clin Diagn Lab Immunol       Date:  2005-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.